L52F (p.Leu52Phe) variant of CASQ2 (Calsequestrin-2)
L52F (p.Leu52Phe) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
L52F (p.Leu52Phe) variant details
- p.Leu52Phe
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available